Post-traumatic stress disorder (PTSD) is a debilitating and chronic condition treated with psychotherapy and psychiatric medications, including antidepressants, but often leaves many with insufficient relief of suffering. The use of 3,4-methylenedioxymethamphetamine (MDMA) as an adjunct to psychotherapy displays considerable promise as a treatment for post-traumatic stress disorder (PTSD) and is…


Previous articleInterview With Ronan Levy
Next articleMarkets for Feb 24: $AION -18.75%, $TRIP +12.64%, $MCUR +11.53%